title: Re: Awh et al.: Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study (Ophthalmology 2015;122:162-9).
authors.affiliation: Quantum Lucid Research Laboratories; University of Michigan-Ann Arbor, Ann Arbor, Michigan. Electronic address: stephen.odaibo@qlucid.com.
authors.forename: Stephen Gbejule
authors.initials: SG
authors.lastname: Odaibo
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D019587:Dietary Supplements; D005260:Female; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide; D011506:Proteins / Q000235:genetics*; D017967:Zinc Compounds / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D011506:Proteins; D017967:Zinc Compounds